BRISTOL-MYERS SQUIBB CO (1BMY.MI) Stock Fundamental Analysis

Europe • Euronext Milan • BIT:1BMY • US1101221083

45.965 EUR
-0.46 (-0.99%)
Last: Jan 26, 2026, 07:00 PM
Fundamental Rating

6

1BMY gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 55 industry peers in the Pharmaceuticals industry. 1BMY has only an average score on both its financial health and profitability. 1BMY is valued quite cheap, while showing a decent growth score. This is a good combination! Finally 1BMY also has an excellent dividend rating. These ratings could make 1BMY a good candidate for value and dividend investing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • 1BMY had positive earnings in the past year.
  • 1BMY had a positive operating cash flow in the past year.
  • In multiple years 1BMY reported negative net income over the last 5 years.
  • Each year in the past 5 years 1BMY had a positive operating cash flow.
1BMY.MI Yearly Net Income VS EBIT VS OCF VS FCF1BMY.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B 10B 15B

1.2 Ratios

  • 1BMY has a Return On Assets (6.23%) which is in line with its industry peers.
  • Looking at the Return On Equity, with a value of 32.55%, 1BMY is in the better half of the industry, outperforming 78.18% of the companies in the same industry.
  • 1BMY's Return On Invested Capital of 17.49% is fine compared to the rest of the industry. 1BMY outperforms 80.00% of its industry peers.
  • 1BMY had an Average Return On Invested Capital over the past 3 years of 11.67%. This is below the industry average of 14.23%.
  • The last Return On Invested Capital (17.49%) for 1BMY is above the 3 year average (11.67%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 6.23%
ROE 32.55%
ROIC 17.49%
ROA(3y)1.77%
ROA(5y)0.82%
ROE(3y)-2.38%
ROE(5y)-2.3%
ROIC(3y)11.67%
ROIC(5y)9.83%
1BMY.MI Yearly ROA, ROE, ROIC1BMY.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

  • 1BMY has a Profit Margin (12.57%) which is in line with its industry peers.
  • Looking at the Operating Margin, with a value of 33.51%, 1BMY is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
  • In the last couple of years the Operating Margin of 1BMY has declined.
  • The Gross Margin of 1BMY (73.15%) is comparable to the rest of the industry.
  • 1BMY's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 33.51%
PM (TTM) 12.57%
GM 73.15%
OM growth 3Y-0.56%
OM growth 5Y-4.29%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.73%
GM growth 5Y1.42%
1BMY.MI Yearly Profit, Operating, Gross Margins1BMY.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

5

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), 1BMY is creating value.
  • 1BMY has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, 1BMY has less shares outstanding
  • The debt/assets ratio for 1BMY is higher compared to a year ago.
1BMY.MI Yearly Shares Outstanding1BMY.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B
1BMY.MI Yearly Total Debt VS Total Assets1BMY.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

  • An Altman-Z score of 2.23 indicates that 1BMY is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • 1BMY has a worse Altman-Z score (2.23) than 60.00% of its industry peers.
  • The Debt to FCF ratio of 1BMY is 3.20, which is a good value as it means it would take 1BMY, 3.20 years of fcf income to pay off all of its debts.
  • 1BMY's Debt to FCF ratio of 3.20 is fine compared to the rest of the industry. 1BMY outperforms 63.64% of its industry peers.
  • A Debt/Equity ratio of 2.41 is on the high side and indicates that 1BMY has dependencies on debt financing.
  • 1BMY's Debt to Equity ratio of 2.41 is on the low side compared to the rest of the industry. 1BMY is outperformed by 81.82% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.41
Debt/FCF 3.2
Altman-Z 2.23
ROIC/WACC2.02
WACC8.68%
1BMY.MI Yearly LT Debt VS Equity VS FCF1BMY.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.3 Liquidity

  • A Current Ratio of 1.27 indicates that 1BMY should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.27, 1BMY is doing worse than 61.82% of the companies in the same industry.
  • 1BMY has a Quick Ratio of 1.17. This is a normal value and indicates that 1BMY is financially healthy and should not expect problems in meeting its short term obligations.
  • 1BMY has a Quick ratio of 1.17. This is in the better half of the industry: 1BMY outperforms 65.45% of its industry peers.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 1.17
1BMY.MI Yearly Current Assets VS Current Liabilites1BMY.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

More info and screens

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 460.68% over the past year.
  • Measured over the past years, 1BMY shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -24.57% on average per year.
  • 1BMY shows a small growth in Revenue. In the last year, the Revenue has grown by 1.26%.
  • 1BMY shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.06% yearly.
EPS 1Y (TTM)460.68%
EPS 3Y-46.63%
EPS 5Y-24.57%
EPS Q2Q%-9.44%
Revenue 1Y (TTM)1.26%
Revenue growth 3Y1.36%
Revenue growth 5Y13.06%
Sales Q2Q%2.77%

3.2 Future

  • Based on estimates for the next years, 1BMY will show a very strong growth in Earnings Per Share. The EPS will grow by 35.29% on average per year.
  • 1BMY is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -5.06% yearly.
EPS Next Y471.99%
EPS Next 2Y130.77%
EPS Next 3Y73.18%
EPS Next 5Y35.29%
Revenue Next Year0.22%
Revenue Next 2Y-4.02%
Revenue Next 3Y-3.34%
Revenue Next 5Y-5.06%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
1BMY.MI Yearly Revenue VS Estimates1BMY.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B 40B
1BMY.MI Yearly EPS VS Estimates1BMY.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6

More info and screens

9

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 8.30, the valuation of 1BMY can be described as reasonable.
  • Based on the Price/Earnings ratio, 1BMY is valued cheaply inside the industry as 96.36% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 28.41. 1BMY is valued rather cheaply when compared to this.
  • 1BMY is valuated reasonably with a Price/Forward Earnings ratio of 8.96.
  • 1BMY's Price/Forward Earnings ratio is rather cheap when compared to the industry. 1BMY is cheaper than 92.73% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 25.64. 1BMY is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 8.3
Fwd PE 8.96
1BMY.MI Price Earnings VS Forward Price Earnings1BMY.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, 1BMY is valued cheaply inside the industry as 92.73% of the companies are valued more expensively.
  • 100.00% of the companies in the same industry are more expensive than 1BMY, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 7.24
EV/EBITDA 6.77
1BMY.MI Per share data1BMY.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as 1BMY's earnings are expected to grow with 73.18% in the coming years.
PEG (NY)0.02
PEG (5Y)N/A
EPS Next 2Y130.77%
EPS Next 3Y73.18%

More info and screens

8

5. Dividend

5.1 Amount

  • 1BMY has a Yearly Dividend Yield of 4.64%, which is a nice return.
  • Compared to an average industry Dividend Yield of 1.95, 1BMY pays a better dividend. On top of this 1BMY pays more dividend than 85.45% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.83, 1BMY pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.64%

5.2 History

  • The dividend of 1BMY is nicely growing with an annual growth rate of 11.67%!
Dividend Growth(5Y)11.67%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 1BMY pays out 82.81% of its income as dividend. This is not a sustainable payout ratio.
  • The dividend of 1BMY is growing, but earnings are growing more, so the dividend growth is sustainable.
DP82.81%
EPS Next 2Y130.77%
EPS Next 3Y73.18%
1BMY.MI Yearly Income VS Free CF VS Dividend1BMY.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B 10B 15B
1BMY.MI Dividend Payout.1BMY.MI Dividend Payout, showing the Payout Ratio.1BMY.MI Dividend Payout.PayoutRetained Earnings

More info and screens

BRISTOL-MYERS SQUIBB CO

BIT:1BMY (1/26/2026, 7:00:00 PM)

45.965

-0.46 (-0.99%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)10-30
Earnings (Next)02-05
Inst Owners81.87%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap93.57B
Revenue(TTM)48.03B
Net Income(TTM)6.04B
Analysts70
Price Target48.98 (6.56%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.64%
Yearly Dividend2.03
Dividend Growth(5Y)11.67%
DP82.81%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)20.98%
Min EPS beat(2)6.92%
Max EPS beat(2)35.04%
EPS beat(4)4
Avg EPS beat(4)18.72%
Min EPS beat(4)6.92%
Max EPS beat(4)35.04%
EPS beat(8)8
Avg EPS beat(8)16.52%
EPS beat(12)11
Avg EPS beat(12)11.66%
EPS beat(16)15
Avg EPS beat(16)10.13%
Revenue beat(2)2
Avg Revenue beat(2)4.61%
Min Revenue beat(2)2.43%
Max Revenue beat(2)6.79%
Revenue beat(4)4
Avg Revenue beat(4)4.63%
Min Revenue beat(4)2.43%
Max Revenue beat(4)6.79%
Revenue beat(8)8
Avg Revenue beat(8)3.95%
Revenue beat(12)9
Avg Revenue beat(12)1.94%
Revenue beat(16)11
Avg Revenue beat(16)1.64%
PT rev (1m)8.16%
PT rev (3m)10.36%
EPS NQ rev (1m)-33.1%
EPS NQ rev (3m)-29.54%
EPS NY rev (1m)-1.3%
EPS NY rev (3m)-0.98%
Revenue NQ rev (1m)0.07%
Revenue NQ rev (3m)2.05%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)1.35%
Valuation
Industry RankSector Rank
PE 8.3
Fwd PE 8.96
P/S 2.31
P/FCF 7.24
P/OCF 6.67
P/B 5.97
P/tB N/A
EV/EBITDA 6.77
EPS(TTM)5.54
EY12.05%
EPS(NY)5.13
Fwd EY11.16%
FCF(TTM)6.35
FCFY13.81%
OCF(TTM)6.9
OCFY15%
SpS19.93
BVpS7.7
TBVpS-9.82
PEG (NY)0.02
PEG (5Y)N/A
Graham Number30.97
Profitability
Industry RankSector Rank
ROA 6.23%
ROE 32.55%
ROCE 23.41%
ROIC 17.49%
ROICexc 22.99%
ROICexgc 117.18%
OM 33.51%
PM (TTM) 12.57%
GM 73.15%
FCFM 31.86%
ROA(3y)1.77%
ROA(5y)0.82%
ROE(3y)-2.38%
ROE(5y)-2.3%
ROIC(3y)11.67%
ROIC(5y)9.83%
ROICexc(3y)13.73%
ROICexc(5y)11.71%
ROICexgc(3y)74.95%
ROICexgc(5y)76.74%
ROCE(3y)15.62%
ROCE(5y)13.15%
ROICexgc growth 3Y-16.88%
ROICexgc growth 5Y3.18%
ROICexc growth 3Y7.41%
ROICexc growth 5Y19.82%
OM growth 3Y-0.56%
OM growth 5Y-4.29%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.73%
GM growth 5Y1.42%
F-Score6
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 2.41
Debt/FCF 3.2
Debt/EBITDA 2.13
Cap/Depr 26.84%
Cap/Sales 2.75%
Interest Coverage 7.66
Cash Conversion 79.11%
Profit Quality 253.39%
Current Ratio 1.27
Quick Ratio 1.17
Altman-Z 2.23
F-Score6
WACC8.68%
ROIC/WACC2.02
Cap/Depr(3y)12.09%
Cap/Depr(5y)10.53%
Cap/Sales(3y)2.56%
Cap/Sales(5y)2.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)460.68%
EPS 3Y-46.63%
EPS 5Y-24.57%
EPS Q2Q%-9.44%
EPS Next Y471.99%
EPS Next 2Y130.77%
EPS Next 3Y73.18%
EPS Next 5Y35.29%
Revenue 1Y (TTM)1.26%
Revenue growth 3Y1.36%
Revenue growth 5Y13.06%
Sales Q2Q%2.77%
Revenue Next Year0.22%
Revenue Next 2Y-4.02%
Revenue Next 3Y-3.34%
Revenue Next 5Y-5.06%
EBIT growth 1Y44.7%
EBIT growth 3Y0.79%
EBIT growth 5Y8.21%
EBIT Next Year220.11%
EBIT Next 3Y49.61%
EBIT Next 5Y23.19%
FCF growth 1Y30.91%
FCF growth 3Y-2.91%
FCF growth 5Y14.03%
OCF growth 1Y28.71%
OCF growth 3Y-2.14%
OCF growth 5Y13.49%

BRISTOL-MYERS SQUIBB CO / 1BMY.MI FAQ

Can you provide the ChartMill fundamental rating for BRISTOL-MYERS SQUIBB CO?

ChartMill assigns a fundamental rating of 6 / 10 to 1BMY.MI.


Can you provide the valuation status for BRISTOL-MYERS SQUIBB CO?

ChartMill assigns a valuation rating of 9 / 10 to BRISTOL-MYERS SQUIBB CO (1BMY.MI). This can be considered as Undervalued.


Can you provide the profitability details for BRISTOL-MYERS SQUIBB CO?

BRISTOL-MYERS SQUIBB CO (1BMY.MI) has a profitability rating of 5 / 10.


Can you provide the financial health for 1BMY stock?

The financial health rating of BRISTOL-MYERS SQUIBB CO (1BMY.MI) is 5 / 10.


Is the dividend of BRISTOL-MYERS SQUIBB CO sustainable?

The dividend rating of BRISTOL-MYERS SQUIBB CO (1BMY.MI) is 8 / 10 and the dividend payout ratio is 82.81%.